HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yali Zheng Selected Research

Peroxisome Proliferator-Activated Receptors (PPAR)

3/2024Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy.
12/2022Nobiletin protects enteric nerves and ameliorates disordered bowel motility in diet-induced obese mice via increasing Trem2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yali Zheng Research Topics

Disease

11Pneumonia (Pneumonitis)
01/2024 - 01/2018
7Neoplasms (Cancer)
10/2022 - 01/2010
6Glioma (Gliomas)
06/2014 - 07/2011
5Infections
01/2024 - 11/2017
4Obesity
01/2023 - 01/2010
4Inflammation (Inflammations)
01/2023 - 01/2020
3Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 01/2020
3Hypoxia (Hypoxemia)
01/2022 - 01/2010
3Septic Shock (Toxic Shock Syndrome)
01/2020 - 10/2016
3Glioblastoma (Glioblastoma Multiforme)
06/2014 - 07/2011
2Dyslipidemias (Dyslipidemia)
01/2023 - 01/2010
2Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 01/2023
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 01/2022
2Confusion (Bewilderment)
01/2021 - 01/2018
2Human Influenza (Influenza)
01/2021 - 01/2021
2Hypertension (High Blood Pressure)
01/2021 - 01/2010
2COVID-19
01/2021 - 01/2021
2Proteinuria
01/2021 - 01/2002
1Wounds and Injuries (Trauma)
05/2024
1Cognitive Dysfunction
05/2024
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2024
1Insulin Resistance
03/2024
1Schizophrenia (Dementia Praecox)
12/2023
1Thrombosis (Thrombus)
11/2023
1Myopia
01/2023
1Blast Crisis (Blast Phase)
01/2023
1Donnai-Barrow syndrome
01/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Lung Neoplasms (Lung Cancer)
10/2022
1Hyperthermia
10/2022
1Connective Tissue Diseases (Connective Tissue Disease)
01/2022
1Breakthrough Infections
01/2022
1Kidney Diseases (Kidney Disease)
01/2021

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
12/2023 - 01/2020
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2010
3Interleukin-6 (Interleukin 6)IBA
12/2023 - 01/2021
3Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2006
316S Ribosomal RNAIBA
01/2023 - 01/2022
3Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2020
3Peptides (Polypeptides)IBA
01/2021 - 01/2012
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2014 - 07/2011
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
05/2012 - 01/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2024 - 12/2022
2Indicators and Reagents (Reagents)IBA
01/2023 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2021
2LipidsIBA
01/2021 - 05/2019
2AlbuminsIBA
01/2021 - 05/2019
2Urea (Carbamide)FDA LinkGeneric
01/2021 - 01/2018
2EpitopesIBA
01/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
04/2020 - 05/2019
2CateninsIBA
06/2014 - 05/2012
2Lithium ChlorideIBA
06/2014 - 01/2012
2Scorpion Venoms (Scorpion Venom)IBA
05/2012 - 01/2012
1SilverIBA
05/2024
1IonsIBA
05/2024
1HydrogelsIBA
05/2024
1rheinIBA
05/2024
1Antipsychotic Agents (Antipsychotics)IBA
05/2024
1Long Noncoding RNAIBA
03/2024
1Monoclonal AntibodiesIBA
01/2024
1Programmed Cell Death 1 ReceptorIBA
12/2023
1LigandsIBA
12/2023
1PolymersIBA
11/2023
1Tyrosine Kinase InhibitorsIBA
01/2023
1Azacitidine (5 Azacytidine)FDA Link
01/2023
1SuspensionsIBA
01/2023
1venetoclaxIBA
01/2023
1Low Density Lipoprotein Receptor-Related Protein-2IBA
01/2023
1ethanoxyhexamercarbideIBA
01/2023
1Cyclin-Dependent Kinase 5IBA
01/2023
1NLR ProteinsIBA
12/2022
1Interleukin-10 (Interleukin 10)IBA
12/2022
1nobiletinIBA
12/2022
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2022
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2022
1Photosensitizing Agents (Photosensitizers)IBA
10/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
1neuromedin NIBA
10/2022
1cinnamyl alcoholIBA
10/2022
1EnkephalinsIBA
10/2022
1Phospholipids (Phosphatides)FDA LinkGeneric
04/2022
1LysophospholipidsIBA
04/2022
1Pyruvic Acid (Pyruvate)IBA
01/2022
1Inactivated VaccinesIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Amino AcidsFDA Link
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2021
1ThrombospondinsIBA
01/2021
1DisintegrinsIBA
01/2021
1AntibodiesIBA
01/2021
1Interleukin-22 (IL-22)IBA
01/2021

Therapy/Procedure

7Therapeutics
01/2023 - 01/2012
2Artificial Respiration (Mechanical Ventilation)
01/2020 - 11/2017
2Drug Therapy (Chemotherapy)
01/2012 - 07/2011
1Intraperitoneal Injections
01/2024
1Photothermal Therapy
10/2022
1Photochemotherapy (Photodynamic Therapy)
10/2022
1Hematopoietic Stem Cell Transplantation
01/2022
1Aftercare (After-Treatment)
01/2021